Analysis of the serotonin transporter polymorphism (5-HTTLPR) in Brazilian patients affected by dysthymia, major depression and bipolar disorder
SIR -The involvement of two polymorphisms, a 3-allele VNTR in intron 2 and a polymorphism in the transcriptional control region upstream of the serotonin transporter (5-hydroxytryptamine transporter or 5-HTT) gene have been analyzed in several psychiatric disorders. 1 In this last one, a long (L) and a short (s) variant of this 5-HTT gene-linked polymorphic region (5-HTTLPR) with different transcriptional efficiency have been identified. The short variant (s) of the 5-HTTLPR results in decreased 5-HTT expression and 5-HT uptake in lymphocytes. 2, 3 Different studies for the VNTR polymorphism failed to reveal any significant association with bipolar and unipolar affective disorders and it is unlikely that it has a major influence on disease risk. 4 However, the analysis of the association between the 5-HTTLPR polymorphism and susceptibility for several psychiatric diseases (including mood disorders, autism, panic disorder, schizophrenia, Alzheimer's disease, obsessive compulsive disorder, personality traits and depressive symptomatology in mood disorders) in different populations has shown some positive but contradictory findings. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Our own study in the Brazilian population 16 as well as all previous single center analyses in Europe did not reveal any significant association between the serotonin transporter polymorphism and affective disorders or schizophrenia. 5, 12, 13, 17 However, when samples from three different European centers were analyzed together, Collier et al 5 found that the frequency of the low-activity short variant (s) of the 5-HTTLPR was higher among patients with affective disorders than in normal controls. A positive association between this polymorphism and unipolar as well as bipolar patients was also observed by Furlong et al 4 through a meta-analysis including data from several studies. These observations suggest that large samples are required in order to detect significant results.
We are not aware, however of previous association studies between the 5-HTTLPR polymorphism and dysthymia. Therefore we have analyzed this polymorphism in a sample of Brazilian patients affected by this disorder as compared to bipolar and major depression patients.
A total of 192 patients were included in the present case-control study: 62 with dysthymia (mean age 40.0 ± 11.5 years), 64 with bipolar disorder (mean age 41.8 ± 12.5 years) and 66 with major depression (mean age 41.3 ± 11.4 years). The patients with dysthymia, bipolar disorder and major depression were selected from the Institute of Psychiatry (Universidade de São Paulo) and the Affective Disorder Unity of the Clinical Hospital (Universidade Federal de Pernambuco). All the patients were diagnosed according to the DSM-IV (APA) and/or CID-10 criteria. Among the patients, about 40% were African/Brazilian, and the remaining 60% were Caucasoids. Normal controls included 152 volunteers who worked at the São Paulo University (or were normal relatives of muscular dystrophy patients without any history of major psychiatric illness) and 45 from the Federal University of Pernambuco with no familial or personal history of psychiatric disorder or treatment, suicide attempt and drug addiction (mean age 38.5 ± 9.8 years). About 50% of the controls were Caucasoids and the remaining were African/Brazilians. The study was approved by the ethical committee from our University and blood samples were drawn from patients and controls after informed consent.
DNA was extracted from blood and the 5-HTTLPR was analyzed by PCR according to the method reported by Lesch et al. 6 According to this method two fragments are generated: the short variant (s) with 484 bp and the long one (L) with 528 bp.
Genotype and gene frequencies were compared among the different groups using chi-squared analysis on contingency tables with allowance for heterogeneity testing and for the analysis of adjusted residuals. 18 The results on 5-HTTLPR genotype frequencies in our sample of normal controls and patients are summarized in Table 1 . Allele frequency estimates and corresponding results of chi-squared analysis for HardyWeinberg proportions are summarized in Table 2 .
Pooling all data of Table 1 together, the gene frequency estimates are: P (L) = 0.603 ± 0.017; P (s) = 0.397 ± 0.017 and The results of the present study suggest no significant association between the 5-HTTLPR polymorphism and dysthymia. In addition, our data suggest that this functional transporter polymorphism does not seem to play a major role in the genetics of bipolar disorder and major depression in Brazilian patients.
Recent population studies of the serotonin transporter protein gene 17, 19 have shown a global variation in the allele frequencies both for the VNTR as well as for the 5-HTTLPR polymorphisms, in particular in the Japanese population as compared to Caucasians. 17 However, it is of interest that, in contrast to the study by Kunugi et al, 17 no significant differences in the 5-HTTLPR polymorphism were found when our mixed (Caucasoid and African/Brazilian) population was compared to the European sample assembled in the meta-analysis study published by Furlong et al, 4 both for normal controls and bipolar patients. These observations suggest that the lack of a significant association between the 5-HTTLPR polymorphism and these three psychiatric disorders in Brazilian patients is probably not due to the ethnic heterogeneity of the studied population.
In conclusion, this is apparently the first study reporting that the 5-HTTLPR polymorphism does not seem to have a major effect in Brazilian patients affected with dysthymia. It will be very important to repeat this analysis in other populations as well as to perform a meta-analysis including samples from different centers in order to assess if a small effect of this polymorphism might be detected in large samples of affected patients.
